These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 27206990

  • 1. Serum GDF-15 level in Behçet's disease: relationships between disease activity and clinical parameters.
    Sarıyıldız MA, Yazmalar L, Batmaz İ, Alpaycı M, Burkan YK, Sula B, Kaplan İ, Yıldız M, Akar ZA, Bozkurt M.
    Int J Dermatol; 2016 Nov; 55(11):1289-1294. PubMed ID: 27206990
    [Abstract] [Full Text] [Related]

  • 2. Is there a relation between clinical disease activity and acute phase response in Behcet's disease?
    Melikoglu M, Topkarci Z.
    Int J Dermatol; 2014 Feb; 53(2):250-4. PubMed ID: 24261602
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of alpha-1 acid glycoprotein and pentraxin 3 in patients with Behçet's disease and relationship with disease activity.
    Yazmalar L, Batmaz İ, Sula B, Alpaycı M, Aydın F, Türkçü F, Yıldız M, Kaplan İ, Bozkurt M, Dağlı AZ, Burkan YK, Sarıyıldız MA.
    Int J Dermatol; 2015 Oct; 54(10):e394-400. PubMed ID: 26147939
    [Abstract] [Full Text] [Related]

  • 4. Serum GDF-15 level in rheumatoid arthritis: relationship with disease activity and subclinical atherosclerosis.
    Tanrıkulu O, Sarıyıldız MA, Batmaz İ, Yazmalar L, Polat N, Kaplan İ, Çevik R.
    Acta Reumatol Port; 2017 Oct; 42(1):66-72. PubMed ID: 27679935
    [Abstract] [Full Text] [Related]

  • 5. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA, Kiziltunç A, Taysi S, Akdemir S, Gündoğdu M.
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [Abstract] [Full Text] [Related]

  • 6. Soluble Tumor Necrosis Factor (TNF)-Like Weak Inducer of Apoptosis (Tweak) Independently Predicts Subclinical Atherosclerosis in Behcet's Disease.
    Icli A, Cure MC, Cure E, Arslan S, Unal M, Sakiz D, Ozucan M, Toker A, Turkmen K, Kucuk A.
    Acta Medica (Hradec Kralove); 2018 Feb; 61(3):86-92. PubMed ID: 30543512
    [Abstract] [Full Text] [Related]

  • 7. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
    Fawzy RM, Said EA, Mohamed SM, Fouad NA, Akl EM.
    Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
    [Abstract] [Full Text] [Related]

  • 8. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
    Kang SE, Lee SJ, Lee JY, Yoo HJ, Park JK, Lee EY, Lee EB, Song YW.
    Clin Exp Rheumatol; 2017 Jun; 35 Suppl 108(6):67-74. PubMed ID: 28770703
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
    Hamzaoui K, Ben Dhifallah I, Karray E, Sassi FH, Hamzaoui A.
    Clin Exp Rheumatol; 2010 Jun; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
    [Abstract] [Full Text] [Related]

  • 10. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.
    Duygulu F, Evereklioglu C, Calis M, Borlu M, Cekmen M, Ascioglu O.
    Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528
    [Abstract] [Full Text] [Related]

  • 11. Is mean platelet volume a new activity criteria in Behçet's disease?
    Uzkeser H, Haliloglu S, Cayir Y, Bilen N, Karaaslan Y, Kosar A, Carlioglu A.
    Blood Coagul Fibrinolysis; 2015 Oct; 26(7):836-9. PubMed ID: 26196194
    [Abstract] [Full Text] [Related]

  • 12. Increased serum interleukin-32 levels in patients with Behçet's disease.
    Ha YJ, Park JS, Kang MI, Lee SK, Park YB, Lee SW.
    Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
    [Abstract] [Full Text] [Related]

  • 13. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdogan A, Sengul A, Dinc A.
    Clin Exp Rheumatol; 2007 Dec; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [Abstract] [Full Text] [Related]

  • 14. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C, Köse K, Caliş M, DemIr M, Kirnap M, Ateş F.
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [Abstract] [Full Text] [Related]

  • 15. Serum anti-lysozyme is associated with disease activity of Behçet's disease.
    Park JS, Kang MI, Ha YJ, Song JJ, Park YB, Lee SK, Lee SW.
    Int J Rheum Dis; 2017 Feb; 20(2):261-268. PubMed ID: 26890818
    [Abstract] [Full Text] [Related]

  • 16. The prevalence of fibromyalgia in patients with Behçet's disease and its relation with disease activity.
    Melikoglu M, Melikoglu MA.
    Rheumatol Int; 2013 May; 33(5):1219-22. PubMed ID: 23052486
    [Abstract] [Full Text] [Related]

  • 17. Preliminary case-control study to evaluate diagnostic values of C-reactive protein and erythrocyte sedimentation rate in differentiating active Crohn's disease from intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome.
    Liu S, Ren J, Xia Q, Wu X, Han G, Ren H, Yan D, Wang G, Gu G, Li J.
    Am J Med Sci; 2013 Dec; 346(6):467-72. PubMed ID: 23689052
    [Abstract] [Full Text] [Related]

  • 18. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease.
    Jung YS, Kim SW, Yoon JY, Lee JH, Jeon SM, Hong SP, Kim TI, Kim WH, Cheon JH.
    Inflamm Bowel Dis; 2011 Oct; 17(10):2130-7. PubMed ID: 21910175
    [Abstract] [Full Text] [Related]

  • 19. Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease.
    Adam B, Calikoglu E.
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):318-20. PubMed ID: 15096143
    [Abstract] [Full Text] [Related]

  • 20. Lipoprotein-associated phospholipase A2 level in patients with Behçet's disease.
    Örem A, Yayli S, Arıca DA, Akcan B, Yücesan FB, Bahadir S.
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e289-93. PubMed ID: 22755553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.